Search research articles
Contact Us
Filters
Showing results (211-220 of 377) with videos related to
Page
of 38
Sort By:
Urologia Internationalis
|
July 12, 2014
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy
Tobias Maurer, Thomas Horn, Michael Souvatzoglou, et al.
Prostate Cancer and Prostatic Diseases
|
December 13, 2017
The use of PET/CT in prostate cancer
Roger Li, Gregory C Ravizzini, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2021
PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease
Francesco Barbato, Wolfgang Peter Fendler, Isabel Rauscher, et al.
The Journal of Urology
|
December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2026
Prognostic Value of [<sup>18</sup>F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer
Sonja Kirchhoff, Bernd Erber, Isabel Rauscher, et al.
EJNMMI Research
|
October 28, 2016
Impact of <sup>68</sup>Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
Christina Bluemel, Fraenze Linke, Ken Herrmann, et al.
EJNMMI Research
|
March 1, 2018
Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis
Christian H Pfob, Matthias Eiber, Peter Luppa, et al.
Page
of 38
Search research articles
Search
Showing results (211-220 of 377) with videos related to
Sort By:
Page
of 38
Urologia Internationalis
|
July 12, 2014
Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy
Tobias Maurer, Thomas Horn, Michael Souvatzoglou, et al.
Prostate Cancer and Prostatic Diseases
|
December 13, 2017
The use of PET/CT in prostate cancer
Roger Li, Gregory C Ravizzini, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 17, 2021
Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, et al.
Urologie (Heidelberg, Germany)
|
April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]
Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 15, 2021
PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease
Francesco Barbato, Wolfgang Peter Fendler, Isabel Rauscher, et al.
The Journal of Urology
|
December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
Tobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2026
Prognostic Value of [<sup>18</sup>F]Flotufolastat PET Using Visual RECIP in Docetaxel-Treated Metastatic Prostate Cancer
Sonja Kirchhoff, Bernd Erber, Isabel Rauscher, et al.
EJNMMI Research
|
October 28, 2016
Impact of <sup>68</sup>Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
Christina Bluemel, Fraenze Linke, Ken Herrmann, et al.
EJNMMI Research
|
March 1, 2018
Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis
Christian H Pfob, Matthias Eiber, Peter Luppa, et al.
Page
of 38